E53.8
Deficiency of other specified B group vitamins
E53.8 is a clinical classification representing the deficiency of specific B-complex vitamins that are not categorized under more common individual codes such as B1, B2, B3, B6, B9, or B12. This code primarily encompasses deficiencies of Biotin (Vitamin B7) and Pantothenic Acid (Vitamin B5). Biotin functions as a critical cofactor for several carboxylase enzymes involved in fatty acid synthesis, gluconeogenesis, and amino acid metabolism. Its deficiency can lead to significant dermatological and neurological manifestations. Pantothenic acid is a required precursor for the synthesis of Coenzyme A (CoA), which is essential for the oxidation of fatty acids and the citric acid cycle. While these deficiencies are rare in populations with diverse diets, they occur in specific clinical contexts such as inborn errors of metabolism, chronic malabsorption, or long-term parenteral nutrition without adequate supplementation.
Clinical Symptoms
- Periorificial dermatitis (erythematous, scaly rash around eyes, nose, and mouth)
- Alopecia (progressive thinning or loss of hair)
- Burning feet syndrome (distal paresthesia and painful heat sensations in the extremities)
- Neurological ataxia
- Hypotonia and muscle weakness
- Seizures (particularly in infants with biotinidase deficiency)
- Severe lethargy and listlessness
- Developmental delay in pediatric patients
- Gastrointestinal distress including nausea and vomiting
- Insomnia and irritability
- Glossitis (inflammation of the tongue)
Common Causes
- Biotinidase deficiency (an autosomal recessive metabolic disorder)
- Chronic consumption of large quantities of raw egg whites (avidin binds to biotin, preventing absorption)
- Prolonged Total Parenteral Nutrition (TPN) lacking B-complex vitamin supplementation
- Malabsorption syndromes (e.g., Short Bowel Syndrome, Crohn's disease, Celiac disease)
- Long-term use of anticonvulsant medications (e.g., phenytoin, carbamazepine, primidone)
- Chronic alcoholism leading to impaired nutrient uptake and storage
- Severe protein-calorie malnutrition
- Disruption of intestinal flora due to prolonged broad-spectrum antibiotic therapy
Documentation & Coding Tips
Specify the exact B-group vitamin deficiency to distinguish from general B-complex deficiencies.
Example: Patient with history of chronic total parenteral nutrition presents with new-onset seborrheic dermatitis and alopecia. Serum biotin levels are significantly below reference range. Diagnosis: Biotin deficiency (E53.8). Plan: Initiate high-dose oral biotin 5mg daily. This chronic condition requires monthly monitoring of integumentary status and laboratory values to evaluate response to therapy.
Billing Focus: Documentation must specify the vitamin, such as Biotin (B7) or Pantothenic acid (B5), rather than using a non-specific B-complex code.
Document the underlying etiology or risk factors such as malabsorption or dietary restrictions.
Example: A 34-year-old female status-post gastric bypass surgery (ICD-10 Z98.84) presents with fatigue and paresthesia. Lab work confirms Pantothenic acid deficiency (E53.8). The deficiency is documented as a direct complication of post-surgical malabsorption, requiring long-term nutritional surveillance.
Billing Focus: Link the deficiency to surgical history or chronic malabsorption syndromes to justify medical necessity for high-complexity office visits.
Detail the clinical manifestations and their impact on the patient's functional status.
Example: Patient exhibits signs of B7 deficiency (E53.8) including diffuse alopecia and erythematous periorificial rash. Patient reports associated depression and lethargy, impacting daily activities of living. These symptoms have been progressive over the last three months despite standard multivitamin use.
Billing Focus: Clinical symptoms provide the medical necessity for diagnostic lab testing and specialized nutrition consultations.
Incorporate specific laboratory values and reference ranges into the clinical narrative.
Example: Serum Pantothenic acid level measured at 0.12 umol/L (Reference: 0.20-1.80 umol/L), confirming diagnosis of Deficiency of other specified B group vitamins (E53.8). Therapeutic intervention with B5 supplementation initiated with repeat testing scheduled in 4 weeks.
Billing Focus: Objective lab data supports the diagnosis code and validates the complexity of the medical decision making.
Clearly document the treatment plan and the patient's adherence or response to therapy.
Example: Patient is currently on 10mg daily Biotin for E53.8. Repeat examination shows partial resolution of dermatitis. Patient is compliant with the regimen but continues to experience mild paresthesia. Plan: Continue current dose and monitor for neurological improvement.
Billing Focus: Treatment response documentation supports the use of subsequent encounter codes and ongoing management levels.
Relevant CPT Codes
-
99213 - Office outpatient visit established patient low MDM 20-29 minutes
Used for routine follow-up on stable vitamin deficiency cases where laboratory results are reviewed and supplements are adjusted.
-
99214 - Office outpatient visit established patient moderate MDM 30-39 minutes
Appropriate for patients with multiple comorbidities or those with systemic symptoms like neuropathy requiring more complex management and coordination.
-
99204 - Office outpatient visit new patient moderate MDM 45-59 minutes
Used for the initial evaluation of a patient presenting with complex symptoms where a specific B-group deficiency is suspected and investigated.
-
82250 - Biotin assay
Directly used to confirm the diagnosis of biotin deficiency under the E53.8 umbrella.
-
84591 - Vitamin not otherwise specified
Used for testing Pantothenic acid (B5) levels, as it does not have its own specific CPT code.
-
97802 - Medical nutrition therapy initial assessment
Necessary for developing a dietary plan to correct deficiencies and prevent recurrence.
-
82492 - Chromatography quantitative column single analyte
Method used to measure levels of specific B vitamins like B5 or B7.
-
99215 - Office outpatient visit established patient high MDM 40-54 minutes
Used when the deficiency results in severe, life-threatening, or highly complex neurological or systemic manifestations.
-
84207 - Pyridoxal phosphate assay
Often ordered as part of a panel for patients with suspected specified B-group deficiencies to rule out or include other B vitamins.
-
99401 - Preventive medicine counseling 15 minutes
Used for counseling patients on dietary changes to prevent future nutritional deficiencies.
Related Diagnoses
- E53.0 - Riboflavin deficiency
- E53.1 - Pyridoxine deficiency
- E53.9 - Vitamin B deficiency, unspecified
- E52 - Niacin deficiency [pellagra]
- D51.9 - Vitamin B12 deficiency anemia, unspecified
- E51.11 - Dry beriberi
- E63.9 - Nutritional deficiency, unspecified
- D81.812 - Biotinidase deficiency
- L21.9 - Seborrheic dermatitis, unspecified
- L65.9 - Nonscarring hair loss, unspecified
- G62.1 - Alcoholic polyneuropathy